Clinical findings support the safety and efficacy of BMND08 at a maximum dosage of 12mg
The product will be launched in March 2024
The agreement licenses the company to launch in the United States, in February 2025, once approved by the U.S. FDA
Highlighting fully integrated organization, robust portfolio, and strategic priorities to drive long-term sustainable growth
BHL will undertake the development and supply of these molecules
Patients visiting OPD sections of hospitals use their Ayushman Bharat Health Account (ABHA) to get instant tokens to save time spent in registration queues
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
_Rupak_Singla_256_384.jpg)
Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi
Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA
_256_384.jpg)
The Vice President also highlighted the importance of preventive healthcare and fitness
Subscribe To Our Newsletter & Stay Updated
